Development of an electronic device for subcutaneous injection of interferon beta-1a in patients with relapsing multiple sclerosis

被引：0
|
作者：
Mikol, D. [1 ]
Verdun, E. [2 ,3 ]
Exell, S. [2 ,3 ]
Devonshire, V. [4 ]
机构：
[1] EMD Serono, Rockland, MA USA
[2] Merck Serono SA, Geneva, Switzerland
[3] Merck KGaA, Darmstadt, Germany
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
MULTIPLE SCLEROSIS | 2010年 / 16卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1282 / 1282
页数：1
相关论文
共 50 条
  • [1] Development of an electronic injection device for subcutaneous interferon beta-1a administration in patients with relapsing multiple sclerosis
    Exell, S.
    Verdun, E.
    Driebergen, R.
    Migliaccio, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S203 - S203
  • [2] An Electronic Device for Subcutaneous Injection of Interferon Beta-1a in Patients with Relapsing Multiple Sclerosis: Clinical Trials Evaluating Patient Satisfaction and Treatment Adherence
    Verdun, E.
    Stubinski, B.
    Exell, S.
    Devonshire, V
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (04) : 536 - 536
  • [3] Assessment of adherence to subcutaneous interferon beta-1a treatment in clinical practice among patients with relapsing multiple sclerosis using an electronic self-injection device
    Baldinetti, F.
    Ghazi-Visser, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 232 - 232
  • [4] Characterizing the factors affecting treatment experience of patients with relapsing-remitting multiple sclerosis using an electronic auto-injection device for subcutaneous interferon beta-1a
    Verdun, E.
    Devonshire, V.
    Cornelisse, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 501 - 501
  • [5] Evolution of the RebiSmart®autoinjector device in support of adherence to subcutaneous interferon beta-1a therapy for relapsing multiple sclerosis
    Arnaud, L.
    Keiser, M.
    Henninger, E.
    Piras, F.
    Seitzinger, A.
    Jack, D.
    Le Masne, Q.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 859 - 859
  • [6] Rebif - Interferon beta-1a - SERONO - Second interferon beta-1a product for relapsing multiple sclerosis
    不详
    FORMULARY, 2002, 37 (04) : 169 - 169
  • [7] PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
    Gitlin, M.
    Snyder, S.
    Jhaveri, M.
    VALUE IN HEALTH, 2019, 22 : S746 - S746
  • [8] PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
    Gitlin, M.
    Snyder, S.
    Jhaveri, M.
    VALUE IN HEALTH, 2019, 22 : S744 - S744
  • [9] Review of subcutaneous interferon beta-1a, delivered via the electronic self-injection device RebiSmart (TM), for the treatment of multiple sclerosis
    Devonshire, Virginia A.
    di Cantogno, Elisabetta Verdun
    THERAPEUTIC DELIVERY, 2011, 2 (11) : 1455 - 1465
  • [10] Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
    Hauser, S. L.
    Bar-Or, A.
    Comi, G.
    Giovannoni, G.
    Hartung, H. -P.
    Hemmer, B.
    Lublin, F.
    Montalban, X.
    Rammohan, K. W.
    Selmaj, K.
    Traboulsee, A.
    Wolinsky, J. S.
    Arnold, D. L.
    Klingelschmitt, G.
    Masterman, D.
    Fontoura, P.
    Belachew, S.
    Chin, P.
    Mairon, N.
    Garren, H.
    Kappos, L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (03): : 221 - 234
12345